PortfoliosLab logo
BIO vs. TMO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BIO and TMO is 1.00, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


Performance

BIO vs. TMO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bio-Rad Laboratories, Inc. (BIO) and Thermo Fisher Scientific Inc. (TMO). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

BIO:

47.80%

TMO:

31.60%

Max Drawdown

BIO:

-3.59%

TMO:

-4.53%

Current Drawdown

BIO:

-0.97%

TMO:

-4.53%

Fundamentals

Market Cap

BIO:

$6.47B

TMO:

$152.18B

EPS

BIO:

-$76.52

TMO:

$17.05

PEG Ratio

BIO:

1.19

TMO:

1.57

PS Ratio

BIO:

2.55

TMO:

3.55

PB Ratio

BIO:

0.97

TMO:

3.12

Total Revenue (TTM)

BIO:

$2.54B

TMO:

$42.90B

Gross Profit (TTM)

BIO:

$1.36B

TMO:

$17.83B

EBITDA (TTM)

BIO:

-$2.52B

TMO:

$10.60B

Returns By Period


BIO

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

TMO

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BIO vs. TMO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIO
The Risk-Adjusted Performance Rank of BIO is 3232
Overall Rank
The Sharpe Ratio Rank of BIO is 3232
Sharpe Ratio Rank
The Sortino Ratio Rank of BIO is 2828
Sortino Ratio Rank
The Omega Ratio Rank of BIO is 2929
Omega Ratio Rank
The Calmar Ratio Rank of BIO is 3939
Calmar Ratio Rank
The Martin Ratio Rank of BIO is 3232
Martin Ratio Rank

TMO
The Risk-Adjusted Performance Rank of TMO is 44
Overall Rank
The Sharpe Ratio Rank of TMO is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of TMO is 44
Sortino Ratio Rank
The Omega Ratio Rank of TMO is 66
Omega Ratio Rank
The Calmar Ratio Rank of TMO is 77
Calmar Ratio Rank
The Martin Ratio Rank of TMO is 11
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BIO vs. TMO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Bio-Rad Laboratories, Inc. (BIO) and Thermo Fisher Scientific Inc. (TMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

BIO vs. TMO - Dividend Comparison

BIO has not paid dividends to shareholders, while TMO's dividend yield for the trailing twelve months is around 0.40%.


TTM20242023202220212020201920182017201620152014
BIO
Bio-Rad Laboratories, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TMO
Thermo Fisher Scientific Inc.
0.40%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

BIO vs. TMO - Drawdown Comparison

The maximum BIO drawdown since its inception was -3.59%, smaller than the maximum TMO drawdown of -4.53%. Use the drawdown chart below to compare losses from any high point for BIO and TMO. For additional features, visit the drawdowns tool.


Loading data...

Volatility

BIO vs. TMO - Volatility Comparison


Loading data...

Financials

BIO vs. TMO - Financials Comparison

This section allows you to compare key financial metrics between Bio-Rad Laboratories, Inc. and Thermo Fisher Scientific Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B20212022202320242025
585.40M
10.36B
(BIO) Total Revenue
(TMO) Total Revenue
Values in USD except per share items

BIO vs. TMO - Profitability Comparison

The chart below illustrates the profitability comparison between Bio-Rad Laboratories, Inc. and Thermo Fisher Scientific Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%45.0%50.0%55.0%60.0%20212022202320242025
52.3%
40.9%
(BIO) Gross Margin
(TMO) Gross Margin
BIO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Bio-Rad Laboratories, Inc. reported a gross profit of 306.00M and revenue of 585.40M. Therefore, the gross margin over that period was 52.3%.

TMO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Thermo Fisher Scientific Inc. reported a gross profit of 4.24B and revenue of 10.36B. Therefore, the gross margin over that period was 40.9%.

BIO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Bio-Rad Laboratories, Inc. reported an operating income of 23.70M and revenue of 585.40M, resulting in an operating margin of 4.1%.

TMO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Thermo Fisher Scientific Inc. reported an operating income of 1.72B and revenue of 10.36B, resulting in an operating margin of 16.6%.

BIO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Bio-Rad Laboratories, Inc. reported a net income of 64.00K and revenue of 585.40M, resulting in a net margin of 0.0%.

TMO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Thermo Fisher Scientific Inc. reported a net income of 1.51B and revenue of 10.36B, resulting in a net margin of 14.5%.